No abstract

Since the beginning of the 20th century, physicians and scientists have been searching for solutions for cardiac valve alterations, increasing studies and developing safer techniques with fewer adverse events. The use of the Starr-Edwards valve for aortic valve replacement in the treatment of aortic regurgitation dates back to the mid-1960s. Its use was rapidly widespread, including about 200,000 patients, although the method had relatively high mortality, related to the care resources available at the time, high thrombogenic risk, the technical difficulty for fixation, and predisposition to hemolytic anemia. Despite this, the durability of this device, associated with drug treatment and rigorous clinical monitoring, stands out. The present report aims to exemplify the satisfactory and lasting result of the Starr-Edwards valve implant in a patient operated on at the Hospital de Base of the Federal District, where the prosthesis was made.